US Patent Issued to The University of North Carolina at Chapel Hill on Aug. 5 for "Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3D printing bioink" (North Carolina Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,149, issued on Aug. 5, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.).

"Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3D printing bioink" was invented by Soumya Rahima Benhabbour (Chapel Hill, N.C.) and Panita Maturavongsadit (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions that include a pharmaceutically active agent, a cellulose nanocrystal or a cellulose nanofiber, a thermogelling biocompatible polymer, and a gelling agent. Such pharmaceutical compositions can be configured as...